Company profile
Prilenia
Dedicated to developing new treatments for neurodegenerative diseases and neurodevelopmental disorders.
- Industry
- Biotechnology Research
- Employees
- 63
- Headquarters
- Boston, Massachusetts
- Founded
- 2018
- LinkedIn followers
- 10,075
- Office locations
- 3
Prilenia company summary
Prilenia is a company in the Biotechnology Research industry, headquartered in Boston, Massachusetts, founded in 2018. On LinkedIn the company has around 63 employees and 10,075 followers. Warmrank detected 38 technologies across 27 categories on prilenia.com, including Anthropic, Apple iCloud Mail, Bootstrap. The company lists 3 office locations.
What technology does Prilenia use?
Warmrank detected 38 technologies on prilenia.com, last checked July 2026. Click any tool to see other companies that use it.
Miscellaneous
DocuSign
Open Graph
RSS
reCAPTCHA
Anthropic
Cloudflare
cdnjsFont scripts
Font Awesome
Google Font API
core-js
jQueryPage builders
Canva
WordPress Block Editor
Apple iCloud Mail
Microsoft 365
Q4 Cookie Monster
TwitterAnalytics
Google AnalyticsCaching
WP Rocket
WordPressCookie compliance
CookieYesShow 14 more technologiesShow fewer technologies
Databases
MySQLGeolocation
ip-apiMarketing automation
MailChimpPaaS
SiteGroundPerformance
Priority HintsProgramming languages
PHPRecruitment & staffing
Lever
Yoast SEOSSL/TLS certificate authorities
Let's EncryptTag managers
Google Tag ManagerUI frameworks
BootstrapVideo players
YouTubeWeb frameworks
Microsoft ASP.NETWeb servers
NginxAbout Prilenia
Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders. Our lead asset is Pridopidine, a first-in-class oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children. Pridopidine is currently being evaluated for the treatment of Huntington’s disease in our global Phase 3 PROOF-HD trial, and for the treatment of ALS in the Phase 2/3 HEALEY platform trial. The company is led by Dr. Michael Hayden, MD, PhD, the founder of five biotech companies and previous President of Global R&D and Chief Scientific Officer at Teva. Michael has directed the development of multiple innovative drug products, leading to 35 approvals between 2012-2018. The Company is based in Naarden, the Netherlands, Herzliya, Israel and Boston, MA in the U.S.
Where is Prilenia located?
Prilenia lists 3 office locations.
Compare companies similar to Prilenia
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Prilenia prilenia.com | Biotechnology Research | 63 | 2018 | Boston, Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Prilenia
What does Prilenia do?
Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders. Our lead asset is Pridopidine, a first-in-class oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children. Pridopidine is currently being evaluated for the treatment of Huntington’s disease in our global Phase 3 PROOF-HD trial, and for the treatment of ALS in the Phase 2/3 HEALEY platform trial. The company is led by Dr. Michael Hayden, MD, PhD, the founder of five biotech companies and previous President of Global R&D and Chief Scientific Officer at Teva. Michael has directed the development of multiple innovative drug products, leading to 35 approvals between 2012-2018. The Company is based in Naarden, the Netherlands, Herzliya, Israel and Boston, MA in the U.S.
What technology does Prilenia use?
Warmrank detected 38 technologies on prilenia.com, including Anthropic, Apple iCloud Mail, Bootstrap, Canva, Cloudflare, CookieYes, DocuSign, Font Awesome.
How many employees does Prilenia have?
Prilenia has around 63 employees on LinkedIn.
Where is Prilenia headquartered?
Prilenia is headquartered in Boston, Massachusetts.
Where does Prilenia have offices?
Prilenia lists 3 office locations, including Boston, Massachusetts, US; Herzliya, Israel, IL; Naarden, NL, NL.
When was Prilenia founded?
Prilenia was founded in 2018.
Build a lead list from companies like Prilenia
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.